Utah Medical Products, Inc. / Fundamentals
Income statement
- Net revenue
€33.70M - Cost of goods sold
€14.47M - Gross profit
€19.23M - SG&A expenses
€7.73M - R&D expenses
€603.17K - EBITDA
€13.17M - D&A
€1.24M - EBIT
€11.04M - Interest expenses
€0.00 - EBT
€13.61M - Tax expenses
€2.49M - Net income
€11.12M
Cash flow statement
- Net deferred tax
-€313.17K - Non-cash items
€1.24M - Changes in working capital
-€760.19K - Operating cash flow
€12.03M - Capex
€146.72K - Other investing cash flow
-€198.20K - Net investing cash flow
-€340.63K - Total cash dividends paid
-€3.59M - Issuance of common stock
€0.00 - Debt repayment
€0.00 - Other financing cash flow
€252.25K - Net financing cash flow
-€20.67M - Foreign exchange effects
-€10.30K - Net change in cash
-€8.99M - Cash at end of period
€71.49M - Free cash flow
€12.18M
Balance sheet
- Cash and cash equivalents
€71.49M - Cash and short-term investments
€71.49M - Total receivables
€3.38M - Inventory
€7.42M - Other current assets
€414.41K - Total current assets
€82.71M - Property, plant & equipment
€8.53M - Goodwill
€0.00 - Intangible assets
€13.88M - Long-term investments
€0.00 - Other non-current assets
€0.00 - Total non-current assets
€22.41M - Total assets
€105.12M - Accounts payable
€784.21K - Short-term debt
€0.00 - Other current liabilities
€2.33M - Total current liabilities
€3.71M - Long-term debt
€230.80K - Deferred tax liabilities
€331.19K - Other non-current liabilities
€422.99K - Total non-current liabilities
€984.98K - Total liabilities
€4.27M - Common stock
€0.00 - Retained earnings
€0.00 - Other equity
€0.00 - Total equity
€100.85M - Total liabilities and shareholders' equity
€105.12M
Company information
- Market capitalization
€160.14M - Employees
155 - Enterprise Value
€101.77M
Company ratios
- Gross margin
-
57.1% Better than peer group: 49.4% - EBITDA margin
-
39.1% Much better than peer group: -6.1% - EBIT margin
-
32.8% Much better than peer group: -11.2% - EBT margin
-
40.4% Much better than peer group: -125.0% - Net margin
-
33.0% Much better than peer group: -13.4% - ROE
-
11.0% Much worse than peer group: 51.2% - ROA
-
10.6% Much better than peer group: -10.4% - Asset turnover
-
32.1% Much worse than peer group: 94.6% - FCF margin
-
35.3% Much better than peer group: -9.8% - FCF yield
7.4% - Efficiency ratio
60.9% - Net sales per employee
-
€217.40K - Net income per employee
-
€71.73K